Lantheus Holdings Inc (LNTH)
74.51
-1.50
(-1.97%)
USD |
NASDAQ |
May 08, 16:00
74.35
-0.16
(-0.21%)
After-Hours: 07:37
Lantheus Holdings Free Cash Flow (Quarterly): 118.96M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 118.96M |
December 31, 2023 | 100.22M |
September 30, 2023 | 102.12M |
June 30, 2023 | -42.96M |
March 31, 2023 | 99.33M |
December 31, 2022 | 100.63M |
September 30, 2022 | 87.48M |
June 30, 2022 | 68.25M |
March 31, 2022 | 7.074M |
December 31, 2021 | 9.345M |
September 30, 2021 | 1.92M |
June 30, 2021 | 23.21M |
March 31, 2021 | 7.298M |
December 31, 2020 | -3.216M |
September 30, 2020 | 4.839M |
June 30, 2020 | -4.411M |
March 31, 2020 | 6.71M |
December 31, 2019 | 17.68M |
September 30, 2019 | 23.11M |
June 30, 2019 | 17.62M |
March 31, 2019 | -0.082M |
December 31, 2018 | 9.94M |
September 30, 2018 | 19.27M |
Date | Value |
---|---|
June 30, 2018 | 14.65M |
March 31, 2018 | -2.801M |
December 31, 2017 | 7.132M |
September 30, 2017 | 12.31M |
June 30, 2017 | 17.16M |
March 31, 2017 | 0.625M |
December 31, 2016 | 10.36M |
September 30, 2016 | 12.86M |
June 30, 2016 | 16.90M |
March 31, 2016 | 2.128M |
December 31, 2015 | 7.894M |
September 30, 2015 | 3.11M |
June 30, 2015 | -14.05M |
March 31, 2015 | 11.66M |
December 31, 2014 | -6.709M |
September 30, 2014 | 18.69M |
June 30, 2014 | -6.986M |
March 31, 2014 | -1.542M |
December 31, 2013 | -5.172M |
September 30, 2013 | 3.376M |
June 30, 2013 | -17.19M |
March 31, 2013 | -1.599M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-42.96M
Minimum
Jun 2023
118.96M
Maximum
Mar 2024
37.26M
Average
17.65M
Median
Free Cash Flow (Quarterly) Benchmarks
Perspective Therapeutics Inc | -9.097M |
Boston Scientific Corp | -81.00M |
Align Technology Inc | 19.30M |
Edwards Lifesciences Corp | -138.80M |
NeuroMetrix Inc | -1.496M |